Neuroelectrics
Neuroelectrics is a Barcelona-based digital brain health company that develops non-invasive brain stimulation (Starstim) and EEG monitoring (Enobio) hardware paired with computational neuroscience modeling (Neurotwin) to serve pharmaceutical companies, CROs, academic institutions, and healthcare providers across 74+ countries.
- Company typePrivate
- Founded2011
- HeadquartersBarcelona, Spain
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Neuroelectrics does
Neuroelectrics is a Barcelona-based digital brain health company, founded in 2011 by Ana Maiques (CEO) and Giulio Ruffini (CTO), that develops non-invasive brain stimulation and EEG monitoring technology for diagnosing and treating neurological and psychiatric disorders. The company builds an integrated platform combining hardware (Enobio wireless EEG systems and Starstim tES-EEG devices in 8, 20, and 32-channel configurations), software (NIC2 device control, MatNIC2 for MATLAB, EEGLAB Plugin, SDK, and LSL/TCP integrations), and computational neuroscience modeling (Neurotwin whole-brain models, Stimweaver montage optimization, NE Cortical Mapper). The platform targets circuital dysfunction in brain networks as an alternative or complement to pharmacology and surgery, with clinical focus areas spanning epilepsy, depression, Alzheimer's, chronic pain, ADHD, Parkinson's, and stroke rehabilitation.
The company operates four revenue streams: hardware device sales (research and clinical/CE-marked/FDA-cleared variants), clinical trial services for pharma companies and CROs, computational modeling services (personalized head models and electric field analytics), and software licenses/integrations. Go-to-market combines direct enterprise sales to pharma, CROs, and academic institutions with a global distributor network covering 74+ countries across Europe, Asia, Americas, Africa, and Middle East. Pricing is quote-based and not publicly disclosed. The company holds ISO 13485 manufacturing certification, CE marking in Europe, and FDA 510(k) clearance for the Enobio Dx clinical variant, with Starstim Eos positioned for clinical epilepsy use and FDA approval pending. To date, 3,000+ devices have been deployed across 100+ clinical trials, supported by 10+ pharma partnerships and a 630+ publication evidence base. Headquarters are in Barcelona with a US regional office in Cambridge, Massachusetts (established 2014); headcount is 11-50 employees.
Neuroelectrics firmographics
Firmographics- Name
- Neuroelectrics
- Legal name
- Neuroelectrics Barcelona S.L.U.
- Website
- https://neuroelectrics.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Neuroelectrics is a Barcelona-based digital brain health company that develops non-invasive brain stimulation (Starstim) and EEG monitoring (Enobio) hardware paired with computational neuroscience modeling (Neurotwin) to serve pharmaceutical companies, CROs, academic institutions, and healthcare providers across 74+ countries.
- Ownership category
- akta.pro rank
Neuroelectrics industry classification
Industry- Product category
- Neuromodulation Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industries
- Epilepsy & Seizure Disorders (HLAKAIAB), Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices) (CRACAQAL), Neurology Telemedicine Platforms (HLALAGAC)
Keywords
Where Neuroelectrics is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices2 records
Markets served
Neuroelectrics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- Hardware Device Sales: Sale of EEG recording devices (Enobio 8, 20, 32) and brain stimulation devices (Starstim tES 8, 20, 32, Starstim Eos) along with accessories including electrodes, caps, cables, and gels. Devices are available in research and clinical versions with varying regulatory certifications.
- Clinical Trial Services: End-to-end EEG monitoring and biomarker services for pharmaceutical companies, CROs, and academic partners conducting clinical trials. Includes protocol development, hardware delivery, site training, data analysis, and statistics support.
- Modeling Services: Computational head model creation, montage optimization (Stimweaver), EEG source localization (NE Cortical Mapper), and electric field analytics for personalized and optimized tES protocols.
- Software Licenses and Integrations: Software products including NIC2 (device control), SDK (application development APIs), MatNIC2 (Matlab integration), EEGLAB Plugin, and LSL/TCP integrations for experiment management and data analysis.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Research and Clinical product lines with multiple channel configurations |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
Neuroelectrics product offering
Product offeringCore offering
Neuroelectrics designs, manufactures, and sells wireless EEG monitoring systems (Enobio) and transcranial electrical stimulation devices (Starstim), integrated with cloud-based software and the Neurotwin computational modeling platform. The company sells these products and end-to-end clinical trial services to pharmaceutical companies, CROs, academic institutions, and hospitals for research and treatment of neurological and psychiatric disorders including epilepsy, depression, Alzheimer's, chronic pain, ADHD, and Parkinson's.
Product overview
Neuroelectrics offers a unified platform for brain monitoring and stimulation comprising two core hardware product lines: Enobio (wireless EEG systems in 8, 20, and 32 channel variants) and Starstim (all-in-one tES-EEG systems with matching channel configurations). The Enobio Dx is the FDA-cleared clinical variant, while Starstim Eos is the clinical brain stimulation device for epilepsy. Supporting these are software products including NIC2 for device control and experiment management, MatNIC2 for MATLAB integration, EEGLAB Plugin for analysis, and LSL/TCP for real-time data streaming. The Neurotwin technology platform provides computational brain modeling for personalized therapy optimization, complemented by Modeling Services and the Stimtargeter Target Editor tool. The portfolio supports research applications in EEG recording, brain stimulation (tDCS/tACS/tRNS), combined EEG-fNIRS monitoring, and clinical trials for epilepsy, depression, Alzheimer's, and other neurological conditions.
Differentiator
Problem solved
Functional benefit
Products and services
- Enobio (8, 20, 32) Wireless medical-grade EEG systems offering high-precision EEG monitoring with 8, 20, or 32 channels, 24-bit dynamic resolution (0.05 µV), and real-time analysis via NIC2 software. CE medically certified in Europe; supports both dry and wet electrodes for neuroscience research.
- Starstim tES (8, 20, 32) All-in-one wireless system combining transcranial electrical stimulation (tDCS/tACS/tRNS, custom waveforms, temporal interference) with simultaneous EEG monitoring. Multi-channel (8/20/32), rechargeable batteries with up to 5 hours of operation, and cortical visualization of tES electric field distribution.
- Starstim Eos Clinical-grade transcranial electrical stimulation device specifically for epilepsy treatment, integrating cloud-based personalized neuromodulation. Currently listed as 'coming soon' on the Neuroelectrics clinical product page.
- Enobio Dx Wireless EEG system for high-precision acquisition in clinical and medical environments. CE medically certified in Europe and FDA 510(k)-Cleared in the US for clinical patient monitoring in hospitals for accurate diagnosis.
- Neurotwin Mechanistic mathematical model of the human brain combining physical and physiological aspects for therapy optimization. Enables whole-brain models to predict physiological effects of transcranial electrical stimulation (tES) and design optimal stimulation protocols tailored to neuropsychiatric disorders.
- Modeling Services Model-driven tES protocol optimization services including head model creation (subject-specific or template-based), Stimweaver montage optimization, NE Cortical Mapper EEG source localization, and electric field analytics with visualization.
- Target Editor (Stimtargeter) Online tool for drawing target maps and determining optimal electrode montage (positions and currents) for tES stimulation, with controls for maximum current intensity and total injected current.
- NIC2 End-to-end management software for tES and EEG interventions and experiments. Provides intuitive interface for real-time analysis, time-frequency visualization (spectrum, spectrogram, band power), and scalp/cortical map rendering.
- MatNIC2 MATLAB-based software for closed-loop experiments and remote NIC2 control, enabling advanced experimental protocols and integration with MATLAB analysis workflows.
- EEGLAB Plugin Plugin for EEG recordings analysis in the MATLAB EEGLAB toolbox, enabling standard or customized proprietary algorithms for advanced signal processing.
- LSL & TCP Integration Real-time sharing of data streams, session events, and reception of external markers via Lab Streaming Layer (LSL) and TCP protocols for synchronization with external systems.
- SDK
Quantifiable outcome
- 41% median seizure reduction in 17-patient open FDA IDE study for drug-resistant epilepsy
- +3 more outcomes
Companies that use Neuroelectrics
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles3 records
Neuroelectrics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration10 records
AI capability7 records
Feature7 records
Neuroelectrics partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- NeuronosticscoreStrategic partnership to deliver integrated EEG solutions for clinical trials, combining Neuroelectrics' EEG hardware with Neuronostics' BioEP digital biomarker analytics platform. Targets pharmaceutical companies, CROs, and academic partners with 20-minute targeted cohort identification EEG and comprehensive data analysis.
- StarlabcoreExclusive partnership for applied neuroscience. Starlab provides neurotechnology expertise in brain stimulation, advanced EEG analysis, and personalized brain modelling. Also serves as exclusive partner providing EEG Insights Consultancy services.
- Clouds of CareminorPartnership for decentralized trial delivery, enabling remote and decentralized trial execution extending EEG data collection beyond the clinic into patients' everyday environments.
- Lucerum KeyminorPartnership for pharmaco EEG neuroanalytics solutions for preclinical drug development and clinical trials.
- Global Distributor NetworkcoreNetwork of authorized distributors across Europe (VISTA-Medical, Mag2Health, GEA Soluzioni, etc.), Asia (Fistar, INFO Instruments, Healthlink Holdings, etc.), Americas (Biolink Medical, Biotecom, MedRent, etc.), Africa (Medical Systems), and Middle East (Farmed Tajhiz, Alpmed, Ameg Tech).
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Neuroelectrics competitors and assessment
Company assessmentDirect peers
- ANT Neuro: ANT Neuro is a major manufacturer of EEG systems and magnetoencephalography (MEG) devices, competing directly with Neuroelectrics' Enobio EEG product line in research and clinical EEG markets.
- Magstim: Magstim manufactures transcranial magnetic stimulation (TMS) systems and other non-invasive brain stimulation equipment for research and clinical use, serving the same neuroscience research and psychiatric treatment markets.
- Soterix Medical: Soterix Medical is the leading direct competitor in non-invasive transcranial direct current stimulation (tDCS) and transcranial electrical stimulation devices, offering overlapping HD-tDCS and tES products for research and clinical applications.
- NeuroPace: NeuroPace develops the RNS System, a closed-loop brain stimulation device for refractory epilepsy, directly competing in the same drug-resistant epilepsy indication targeted by Neuroelectrics' Starstim platform.
Emerging players
- eNeura: eNeura develops non-invasive transcranial magnetic stimulation devices for migraine treatment, representing a focused emerging player in the non-invasive neuromodulation space targeting neurological disorders.
- Ybrain: Ybrain is a Korean neurotechnology company developing wearable tDCS devices for depression and other neurological conditions, representing an emerging regional competitor with overlapping depression treatment focus.
- Wave Neuroscience: Wave Neuroscience offers personalized neurostimulation and EEG-guided brain health treatments, representing an emerging player with overlapping personalized neuromodulation and EEG-based therapy positioning.
Broad incumbents
- Brainlab: Brainlab is a large medical technology company offering neurosurgical planning and brain stimulation workflow software that intersects with Neuroelectrics' computational modeling and clinical trial analytics offerings.
- Compumedics: Compumedics manufactures clinical EEG and sleep diagnostics systems globally, representing a broader incumbent in the EEG monitoring market with overlapping clinical neurology customer base.
- LivaNova: LivaNova offers Vagus Nerve Stimulation (VNS) Therapy, an implantable neuromodulation device for drug-resistant epilepsy and depression, representing an established alternative in the same refractory epilepsy market.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Neuroelectrics social profiles
Digital presenceNeuroelectrics compliance and trust
Trust signalCompliance3 records
Neuroelectrics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Neuroelectrics leadership team
Management profileNumber of profiles
Profiles3 records
Neuroelectrics funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Neuroelectrics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Neuroelectrics
What does Neuroelectrics do?
Neuroelectrics designs, manufactures, and sells wireless EEG monitoring systems (Enobio) and transcranial electrical stimulation devices (Starstim), integrated with cloud-based software and the Neurotwin computational modeling platform. The company sells these products and end-to-end clinical trial services to pharmaceutical companies, CROs, academic institutions, and hospitals for research and treatment of neurological and psychiatric disorders including epilepsy, depression, Alzheimer's, chronic pain, ADHD, and Parkinson's.
Is Neuroelectrics a public or private company?
Neuroelectrics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Neuroelectrics founded?
Neuroelectrics was founded in 2011. It employs 11 to 50 people.
Where is Neuroelectrics based?
Neuroelectrics is headquartered in Barcelona, Spain, in the Europe region.
How does Neuroelectrics make money?
Four revenue lines are on record. Hardware Device Sales are the primary driver. The others are clinical Trial Services, modeling Services and software Licenses and Integrations.
Who are Neuroelectrics's main competitors?
Direct peers on record are ANT Neuro, Magstim, Soterix Medical and NeuroPace. Emerging players are eNeura, Ybrain and Wave Neuroscience. Broad incumbents are Brainlab, Compumedics and LivaNova.
Does Neuroelectrics have an API?
Yes. Neuroelectrics offers a Software Development Kit (SDK) for application development with Enobio devices. The SDK enables integration of raw EEG signals into investigational apps. The platform also supports LSL (Lab Streaming Layer) and TCP Integration for real-time sharing of data streams, session events, and reception of external markers. Developer documentation is at www.neuroelectrics.com/sdk.
What industry is Neuroelectrics in?
Neuroelectrics's product category is Neuromodulation Devices. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLAKAIAB, Epilepsy & Seizure Disorders. Its NAICS code is 334510 and its SIC code is 3845.